Imatinib Mesylate for the Treatment of Steroid-Refractory Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2015.03.006
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2015
Authors
Publisher
Elsevier BV